How one family gave a critical boost to gene therapy research

A family deeply affected by the rare and devastating Sanfilippo syndrome committed to raising millions for gene therapy research, which has now paid off as the Food and Drug Administration approved a groundbreaking gene therapy. This approval marks a significant leap forward in treating genetic disorders, offering hope to countless families grappling with similar challenges. The funding and advocacy from this family highlight the crucial role of patient-driven initiatives in advancing medical science and making life-saving treatments a reality.